Addiction Cure Therapeutic Sciences Inc
OperatingHealthcare · Founded 2020
Biotech firm advancing first in class therapeutics aiming to treat and cure drug and alcohol addiction
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Dec 31, 2021| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Preferred stockpreferred | 2,000 | — | 0.02% | — |
| common stock | 10,000,000 | 1 | 100.0% | $0.50Sep 2022 |
| Total | 10,002,000 | 100% |
Sold to the crowd
- Reg CF · Sep 202263,804 shares at $0.50$31.9K
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
2 peopleNames and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGAR- Form D/AApr 3, 20240001915302-24-000001EDGAR
- Form DApr 11, 20230001915302-23-000001EDGAR
- Form C-WApr 3, 20230001669191-23-000307EDGAR
- Form C/AFeb 27, 20230001669191-23-000182EDGAR
- Form C/AJan 4, 20230001669191-23-000006EDGAR
- Form C/ANov 14, 20220001669191-22-001053EDGAR
- Form C/ASep 12, 20220001669191-22-000884EDGAR
- Form CSep 12, 20220001669191-22-000874EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.